Shares of Danaher Corp. DHR inched 0.38% higher to $239.10 Tuesday, on what proved to be an all-around dismal trading session ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Danaher (NYSE:DHR – Get Free Report) had its price objective cut by analysts at Citigroup from $305.00 to $285.00 in a note ...

CWA Asset Management Group LLC reduced its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 13.1% during the 4th ...

The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$4.03 ...

Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial ...

One writer explores the passions of a musically gifted alum — and the complexity of his timeless instrument, the organ.

Rising incidence of oral cancer along with an increase in the number of dental treatments is expected to propel the global ...

The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks.

Heading into fourth-quarter earnings season, investors will need to balance their enthusiasm for President-elect Donald Trump ...